CalciMedica, Inc. – NASDAQ:CALC
CalciMedica stock price today
CalciMedica stock price monthly change
CalciMedica stock price quarterly change
CalciMedica stock price yearly change
CalciMedica key metrics
Market Cap | 38.21M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.63 |
Revenue | N/A |
EBITDA | -17.62M |
Income | -14.93M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCalciMedica stock price history
CalciMedica stock forecast
CalciMedica financial statements
| Jun 2023 | 0 | -6.30M | |
|---|---|---|---|
| Sep 2023 | 0 | -4.61M | |
| Dec 2023 | 0 | -4.14M | |
| Mar 2024 | 0 | 130K |
| 2025 | 12.5M | -27.86M | -222.93% |
|---|---|---|---|
| 2026 | 2.8M | -32.45M | -1158.93% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 20245000 | 4.02M | 19.88% |
|---|---|---|---|
| Sep 2023 | 15845000 | 3.68M | 23.26% |
| Dec 2023 | 12185000 | 4.02M | 33.06% |
| Mar 2024 | 27134000 | 9.88M | 36.44% |
| Jun 2023 | -12.19M | 9.75M | -2.86M |
|---|---|---|---|
| Sep 2023 | -4.57M | -2.94M | 72K |
| Dec 2023 | -3.61M | -2.67M | 175K |
| Mar 2024 | -4.71M | -13.10M | 19.04M |
CalciMedica alternative data
| Dec 2023 | 14 |
|---|---|
| Jan 2024 | 14 |
| Feb 2024 | 14 |
| Mar 2024 | 14 |
| Apr 2024 | 14 |
| May 2024 | 14 |
| Jun 2024 | 14 |
| Jul 2024 | 13 |
CalciMedica other data
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 2717536 | 0 |
| Apr 2024 | 4000 | 0 |
| Jun 2024 | 64721 | 0 |
| Aug 2024 | 65000 | 0 |
| Nov 2024 | 322154 | 0 |
| Dec 2024 | 4800 | 0 |
-
What's the price of CalciMedica stock today?
One share of CalciMedica stock can currently be purchased for approximately $2.75.
-
When is CalciMedica's next earnings date?
Unfortunately, CalciMedica's (CALC) next earnings date is currently unknown.
-
Does CalciMedica pay dividends?
No, CalciMedica does not pay dividends.
-
How much money does CalciMedica make?
CalciMedica has a market capitalization of 38.21M.
-
What is CalciMedica's stock symbol?
CalciMedica, Inc. is traded on the NASDAQ under the ticker symbol "CALC".
-
What is CalciMedica's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of CalciMedica?
Shares of CalciMedica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does CalciMedica have?
As Jul 2024, CalciMedica employs 13 workers, which is 7% less then previous month and 7% less then previous quarter.
-
When CalciMedica went public?
CalciMedica, Inc. is publicly traded company for more then 2 years since IPO on 14 Jun 2023.
-
What is CalciMedica's official website?
The official website for CalciMedica is calcimedica.com.
-
Where are CalciMedica's headquarters?
CalciMedica is headquartered at 505 Coast Boulevard South, La Jolla, CA.
-
How can i contact CalciMedica?
CalciMedica's mailing address is 505 Coast Boulevard South, La Jolla, CA and company can be reached via phone at 858-952-5500.
CalciMedica company profile:
CalciMedica, Inc.
calcimedica.comNASDAQ
13
Biotechnology
Healthcare
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
La Jolla, CA 92037
CIK: 0001534133
ISIN: US38942Q2021
CUSIP: 38942Q202
